Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
4,047,383
-
Shares change
-
+42,331
-
Total reported value, excl. options
-
$172,153,949
-
Value change
-
+$1,755,771
-
Number of buys
-
30
-
Number of sells
-
-31
-
Price
-
$42.54
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2017
89 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q3 2017.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,047,383 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (925,676 shares), MORGAN STANLEY (641,522 shares), BANK OF AMERICA CORP /DE/ (508,415 shares), Psagot Investment House Ltd. (270,872 shares), Wharton Business Group, LLC (221,765 shares), UBS Group AG (149,530 shares), TWO SIGMA SECURITIES, LLC (131,720 shares), Baird Financial Group, Inc. (128,868 shares), JPMORGAN CHASE & CO (101,719 shares), and BNP PARIBAS ARBITRAGE, SA (100,000 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.